El Hospital General Universitario de Alicante Doctor Balmis es un hospital público dependiente de la Consejería de Sanidad Universal y Salud Pública de la Generalidad Valenciana situado en la ciudad española de Alicante.​

During the past decade, Hospital General de Alicante conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 16 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General de Alicante" #1 sponsor was "PETHEMA Foundation" with 16 trials, followed by "Spanish Lung Cancer Group" with 7 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "ETOP IBCSG Partners Foundation" with 4 trials sponsored and "Fundación GECP" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Alicante" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "ARTTIC International Management Services" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General de Alicante" are "Acute Lymphoblastic Leukemia" (7 trials), "Coronary Artery Disease" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Acromegaly" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Hospital General de Alicante" in a lesser frequency.

Most popular intervention types in "Hospital General de Alicante" are "Drug" (63 trials), "Device" (11 trials), "Procedure" (8 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (7 trials), "Placebo" (7 trials), "Cyclophosphamide" (6 trials), "Docetaxel" (6 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Alicante" are 83 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General de Alicante". undefined are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Hospital General de Alicante, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Alicante, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 6 trials that are defined as “Not Applicable".